CONFIRM anti-MITF (C5/D5) Mouse Monoclonal Primary Antibody

Skip to Content


Skip over Generic Navigation

  • Select your country:
DIAGNOSTICS F. Hoffmann-La Roche Ltd

CONFIRM anti-MITF (C5/D5) Mouse Monoclonal Primary Antibody

CONFIRM anti-MITF (C5/D5) Mouse Monoclonal Primary Antibody, melanoma, 150x
Catalog Number:790-4367
Ordering Code:05549175001
Quantity:50 tests
Controls:Melanoma
Isotypes:IgG1
Clone Name:C5/D5
Species:Mouse
Localization:Nuclear
Regulatory Status:IVD


This antibody is intended for in vitro diagnostic (IVD) use. Ventana Medical Systems’ (Ventana) CONFIRM anti-MITF (C5/D5) Mouse Monoclonal Primary Antibody is a mouse monoclonal cocktail. This antibody cocktail reagent detects microphthalmia transcription factor (MITF) proteins 52-56KD of MITF expressing cells in normal and neoplastic tissues. This antibody is used in the identification of melanotic lesions such as malignant melanoma and melanotic neurofibroma. The antibody is intended for qualitative staining in sections of formalin fixed, paraffin embedded tissue. The clinical interpretation of any staining or absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests.


Health Care Provider Notice
X
This website is intended for healthcare professionals only.

The content on this website is intended for healthcare professionals only. Information intended for the general public can be found on Roche.com. Please confirm that you are a medical professional before accessing the content of this website.

Yes, I hereby certify that I am a healthcare professional. Continue
Third-Party Link Disclosure
X
Disclosure for Links to Third-Party Websites

You are now leaving the Roche website. The site you are about to visit is operated by third-parties. The link to this site neither makes nor implies any representation or warranty for any products or services offered on a third-party site and is intended only to enable convenient access to the third-party site and for no other purpose.

Continue